Regular Article
Immunohistochemical Localization of Acetaminophen in Target Tissues of the CD-1 Mouse: Correspondence of Covalent Binding with Toxicity

https://doi.org/10.1006/faat.1995.1029Get rights and content

Abstract

Immunohistochemical Localization of Acetaminophen in Target Tissues of the CD-1 Mouse: Correspondence of Covalent Binding with Toxicity. Emeigh Hart, S. G., Cartun, R. W., Wyand, D. S., Khairallah, E. A., and Cohen, S. D. (1995). Fundam. Appl. Toxicol. 24, 260-274.

Administration of hepatotoxic doses of acetaminophen (APAP) to mice results in necrosis, not only of liver cells but of renal proximal tubules and bronchiolar and olfactory epithelium. In the liver, covalent binding is localized to the centrilobular hepatocytes which later undergo necrosis. This study was undertaken to compare the cellular distribution of bound APAP in all four major target tissues with that of cytochrome P4502E1 (a P450 isoenzyme commonly associated with APAP bioactivation), with emphasis on the cell types which later undergo necrosis. Tissues were collected from mice at selected times after APAP administration (600 mg/kg, po) and fixed by microwave irradiation for immunohistochemistry, or in formalin for histopathological study. Immunohistochemical localization of bound APAP was performed on 5 μm paraffin sections using an affinity-purified anti-APAP antibody. Similar tissues from naive mice were used for immunohistochemical localization of cytochrome P4502E1 (using a polyclonal sheep anti-P4502E1 antibody). Positive staining with both the anti-APAP and the anti-P4502E1 antibodies was similar in distribution, being present in the cell types which become damaged by APAP in all four target tissues. These results demonstrate that covalent binding and subsequent necrosis are localized in common with cytochrome P4502E1, suggesting that, as in the liver, toxicity in extrahepatic targets is also related to the ability of these tissues to activate APAP in situ.

References (0)

Cited by (73)

  • Mitochondrial versus microsomal bioactivation of paracetamol by human liver and kidney tissues

    2022, Toxicology Letters
    Citation Excerpt :

    PAR-induced renal toxicity occurs in the absence of a significant liver toxicity, even in the hepatectomised mice given PAR. In addition, renal protein covalent binding was also observed in-situ (Hart et al., 1994, 1995). Taken together, these data strongly suggested that NAPQI is not transferred from the liver, instead it is formed locally in the kidney.

  • 4-methylpyrazole protects against acetaminophen-induced acute kidney injury

    2020, Toxicology and Applied Pharmacology
    Citation Excerpt :

    Biomarkers measured in blood from APAP overdose patients also supported this mechanism (McGill et al., 2012a). Our current studies confirmed previous reports (Emeigh Hart et al., 1991; Hart et al., 1994, 1995) that APAP can be metabolized by Cyp2E1 in the kidney forming the reactive metabolite NAPQI, which depletes GSH and form protein adducts. However, hallmarks of APAP-induced liver injury such as mitochondrial protein adduct formation, JNK activation and P-JNK translocation to the mitochondria were not detectable in the kidney at renal subtoxic and toxic doses of APAP.

  • Pulmonary Irritant Responses: Oxidants and Electrophiles

    2018, Comprehensive Toxicology: Third Edition
  • Mechanisms of Toxicant-Induced Acute Kidney Injury

    2018, Comprehensive Toxicology: Third Edition
View all citing articles on Scopus
View full text